Uganda may miss first shipment of lenacapavir as approval process stalls
HIV activists are raising alarms over delays by the National Drug Authority (NDA) to evaluate and license the long-acting HIV prevention injection lenacapavir, despite Uganda being among the first countries expected to receive donated doses. Lenacapavir, administered twice a year, has shown high effectiveness as pre-exposure prophylaxis (PrEP) in clinical trials carried out among adolescent…